• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    Brainstorm Cell Therapeutics Inc. (BCLI)

    -NasdaqCM
    2.24 Down 0.15(6.28%) Apr 29, 4:00PM EDT
    Prev Close:2.39
    Open:2.36
    Bid:1.43 x 200
    Ask:3.00 x 1000
    1y Target Est:5.00
    Beta:1.20067
    Earnings Date:May 12 - May 16 (Est.)
    Day's Range:2.20 - 2.36
    52wk Range:1.90 - 4.02
    Volume:71,960
    Avg Vol (3m):50,989
    Market Cap:41.78M
    P/E (ttm):N/A
    EPS (ttm):-0.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BCLI

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.97
    Quarterly EPS Est (Mar-16) :-0.25
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Brainstorm Cell Therapeutics Inc., a biotechnology company, develops adult stem cell therapies for neurodegenerative disorders, such as amyotrophic lateral sclerosis, multiple sclerosis, and Parkinson’s disease. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback